Forty years of combined oral contraception: The evolution of a revolution

Medical Journal of Australia

Volumn 173, Issue 10, 2000, Pages 541-544

  Fraser, I S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GESTAGEN; GONADORELIN; GRISEOFULVIN; ORAL CONTRACEPTIVE AGENT; RIFAMPICIN;

BREAST CANCER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTRACEPTION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; FERTILITY; HORMONE INHIBITION; HUMAN; MENSTRUATION DISORDER; NONHUMAN; OVULATION INHIBITION; PATIENT COMPLIANCE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; TABLET FORMULATION; THROMBOEMBOLISM;

EID: 0034693713     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb139325.x     Document Type: Review

References (29)

1. The population explosion
2. Hormonal sterilisation of female animals
3. Mechanism of estrin therapy in the relief of dysmenorrhoea
4. Gregory Pincus and steroidal contraception: A new departure in the history of mankind
5. A new low-dose monophasic combination oral contraceptive with levonorgestrel 100μg and ethinyl oestradiol 20 μg
6. The relative reliability of oral contraceptives: Findings of an epidemiological study
7. Contraceptive failure in the United States: Revised estimates from the 1982 National Survey of Family Growth
8. Benefits and risks of steroidal contraception
9. The influence of steroids on gynecologic cancers
10. Non-contraceptive health benefits of oral steroidal contraceptives
11. Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives
12. Epidemiology of endometriosis in women attending family planning clinics
13. Oral contraceptive use and benign gynecologic conditions
14. Oral contraceptives and pelvic inflammatory disease
15. Primary infertility and oral contraceptive steroid use
16. A placebo-controlled, double-blind crossover investigation of the side-effects attributed to oral contraception
17. The effects of steroidal contraceptives on the well-being and sexuality of women
18. Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Data Base and the UK MediPlus Data Base
19. Reproductive choices in 2000: The relative safety of current oral contraceptives
20. Risk factors for acute myocardial infarction in women
21. Stroke and steroidal hormonal contraception
22. Estrogen and progestin components of oral contraception: Relationship to vascular disease
23. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies
24. Epidemiology of hepatocellular adenoma: The role of oral contraceptive use
25. Oral contraceptives and cervical cancer risk in Costa Rica: Detection bias or casual association?
26. Evidence-guided prescribing of combined oral contraceptives: A consensus statement